Rating History for Keryx Biopharmaceuticals (KERX) by Raymond James

More Stocks Rated by Raymond James | Latest Ratings for KERX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/12/2018 Reni Benjamin Downgrade Market Perform
(Outperform)		 N/A
(N/A)		 3.03
(3.36)		 10.89% Details